表紙
市場調査レポート

日本の病院・民間試験所向け治療薬物モニタリング(TDM)市場

Japan Therapeutic Drug Monitoring (TDM) Market: Future Horizons and Growth Strategies--Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

発行 Venture Planning Group 商品コード 273574
出版日 ページ情報 英文 247 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。

Local License: 同一事業所内

Back to Top
日本の病院・民間試験所向け治療薬物モニタリング(TDM)市場 Japan Therapeutic Drug Monitoring (TDM) Market: Future Horizons and Growth Strategies--Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
出版日: ページ情報: 英文 247 Pages
概要

当レポートでは、日本における病院・民間試験所向けの治療薬物モニタリング(TDM)の関連市場(装置・試薬など)について分析し、技術・市場の最新動向や将来展望、今後の市場規模・市場シェアの動向、市場が抱える課題、主要企業のプロファイルと市場戦略といった情報を盛り込んで、概略以下の構成でお届けします。

イントロダクション

世界市場と技術概要

  • 主な治療薬物モニタリング検査
    • 概要
    • カルバマゼピン
    • シクロスポリン
    • ジゴキシン
    • エベロリムス
    • ゲンタマイシン
    • ラモトリジン/ラミクタル
    • レベチラセタム
    • リドカイン
    • リチウム
    • フェニトイン
    • NAPA/プロカインアミド
    • キニジン
    • シロリムス
    • タクロリムス
    • トピラマート
    • テオフィリン
    • バルプロ酸
  • 検査装置のレビュー:機能上の特徴、大型/中型/小型/POC解析装置(全22社分)
  • 主な対外診断技術とその潜在的な用途
    • モノクローナル・ポリクローナル抗体
    • 免疫学的検定
      • 技術的原則
      • 化学的発光法
      • 酵素免疫検定(EIA)
      • 放射性免疫検定(RIA)
      • 免疫沈澱
      • 親和クロマトグラフィー
    • タンデム質量分析
    • ITおよびオートメーション
    • ドライケミストリー
    • バイオセンサー
  • 市場規模・成長率、主要サプライヤーの市場シェア

代替的な市場普及戦略

  • 内部開発
  • 共同事業協定
  • 大学との契約
  • 分散型検査市場の流通戦略
    • マーケティングのアプローチ
    • 製品の複雑性
    • 顧客の選好
    • 既存のサプライヤー
    • 新規参入サプライヤー
    • 流通業者の主な種類
    • 市場の細分化

潜在的な市場参入障壁とリスク

  • 市場の成熟化
  • コスト抑制
  • 競争
  • 最先端技術とその限界
  • 特許保護
  • 規制による抑制
  • 分散型検査市場の課題

競合企業評価

  • Abbott Laboratories
  • AdnaGen
  • Agilent Technologies
  • Beckman Coulter/Danaher
  • Biomedical Diagnostics
  • BioMerieux
  • Bio-Rad
  • DiaSorin
  • 栄研化学
  • 富士レビオ/Innogenetics
  • Instrumentation Laboratory
  • 協和メデックス
  • Matritech/Alere
  • Ortho-Clinical Diagnostics
  • Quest Diagnostics
  • Roche
  • Siemens
  • シスメックス
  • Thermo Fisher
  • 東ソー
  • 和光純薬工業
  • Wallac/PE

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPCC20435

This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the Japanese therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.

The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid and Vancomycin.

During the next five years, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.

This report is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.

Contains 247 pages and 17 tables

Table of Contents

Introduction

Worldwide Market and Technology Overview

  • A. Major Therapeutic Drug Monitoring Tests
    • 1. Overview
    • 2. Carbamazepine
    • 3. Cyclosporin
    • 4. Digoxin
    • 5. Everolimus
    • 6. Gentamicin
    • 7. Lamotrigine/Lamictal
    • 8. Levetiracetam
    • 9. Lidocaine
    • 10. Lithium
    • 11. Phenytoin
    • 12. NAPA/Procainamide
    • 13. Quinidine
    • 14. Sirolimus
    • 15. Tacrolimus
    • 16. Topirimate
    • 17. Theophylline
    • 18. Valproic Acid
  • B. Instrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzers manufactured by Abaxis, Abbott, Alere/Inverness, Alfa Wassermann, AMS, Awareness Technologies, Beckman Coulter/Olympus, Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba, Medica, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox, Roche, Siemens, Tosoh, Vital Diagnostics and other suppliers
  • C. Major In Vitro Diagnostic Technologies And Their Potential Applications
    • 1. Monoclonal and Polyclonal Antibodies
    • 2. Immunoassays
      • a. Technological Principle
      • b. Chemiluminescence
      • c. Enzyme Immunoassays (EIA)
        • Overview
        • ELISA
        • EMIT
        • Electrochemical
      • d. Radioimmunoassays (RIA)
      • e. Immunoprecipitation
      • f. Affinity Chromatography
    • 3. Tandem Mass Spec
    • 4. IT and Automation
    • 5. Dry Chemistry
    • 6. Biosensors
  • D. Market Size, Growth and Major Supplier Shares

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

Competitive Assessments

  • Abbott Laboratories
  • AdnaGen
  • Agilent Technologies
  • Beckman Coulter/Danaher
  • Biomedical Diagnostics
  • BioMerieux
  • Bio-Rad
  • DiaSorin
  • Eiken
  • Fujirebio/Innogenetics
  • Instrumentation Laboratory
  • Kyowa Medex
  • Matritech/Alere
  • Ortho-Clinical Diagnostics
  • Quest Diagnostics
  • Roche
  • Siemens
  • Sysmex
  • Thermo Fisher
  • Tosoh
  • Wako
  • Wallac/PE

List of Tables

  • Major Companies Developing or Marketing TDM Tests
  • Major Companies Developing or Marketing Digoxin Tests
  • Major Companies Developing or Marketing Lithium Tests
  • Major Companies Developing or Marketing Phenytoin Tests
  • Major Companies Developing or Marketing Theophylline Tests
  • Major Companies Developing or Marketing Valproic Tests
  • Major Companies Developing or Marketing
  • Biosensors for Genetic Disease Testing
  • Japan, Laboratories Performing TDM Tests By Market Segment
  • Japan, Hospital Laboratories Performing TDM Tests By Bed Size
  • Japan, Commercial/Private Laboratories Performing TDM Tests By Annual Test Volume
  • Japan, TDM Test Volume Forecast By Market Segment
  • Japan, Hospital Laboratories, TDM Test Volume Forecast by Assay
  • Japan, Commercial/Private Laboratories, TDM Test Volume Forecast by Assay
  • Japan, TDM Reagent Market Forecast By Market Segment
  • Japan, Hospital Laboratories, TDM Reagent Market Forecast by Assay
  • Japan, Commercial/Private Laboratories, TDM Reagent Market Forecast by Assay
  • Japan, Major Suppliers of Immunodiagnostic Products, Estimated Market Shares
Back to Top